IN2013MU01318A - - Google Patents

Info

Publication number
IN2013MU01318A
IN2013MU01318A IN1318MU2013A IN2013MU01318A IN 2013MU01318 A IN2013MU01318 A IN 2013MU01318A IN 1318MU2013 A IN1318MU2013 A IN 1318MU2013A IN 2013MU01318 A IN2013MU01318 A IN 2013MU01318A
Authority
IN
India
Prior art keywords
pellets
dabigatranetexile
talc
pharmaceutical composition
organic acid
Prior art date
Application number
Inventor
Vemula Sathyanarayana
S Vemula Mousumi
Fazil Abdul
Original Assignee
Ensure Pharma Technologies Private Ltd V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ensure Pharma Technologies Private Ltd V filed Critical Ensure Pharma Technologies Private Ltd V
Priority to IN1318MU2013 priority Critical patent/IN2013MU01318A/en
Publication of IN2013MU01318A publication Critical patent/IN2013MU01318A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The present invention relates to pharmaceutical composition comprising Dabigatranetexile methyl sulfonate pellets without talc and Organic acid pellets.
IN1318MU2013 2013-04-05 2013-04-05 IN2013MU01318A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1318MU2013 IN2013MU01318A (en) 2013-04-05 2013-04-05

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1318MU2013 IN2013MU01318A (en) 2013-04-05 2013-04-05

Publications (1)

Publication Number Publication Date
IN2013MU01318A true IN2013MU01318A (en) 2015-04-10

Family

ID=54395739

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1318MU2013 IN2013MU01318A (en) 2013-04-05 2013-04-05

Country Status (1)

Country Link
IN (1) IN2013MU01318A (en)

Similar Documents

Publication Publication Date Title
DK2988791T3 (en) CROSS-SILK HYALURONIC ACID COMPOSITION
DK3030262T3 (en) COMBINED PHARMACEUTICAL COMPOSITION
HK1214618A1 (en) Stabilized compositions comprising hyaluronic acid
IL243627A (en) High potency pancreatin pharmaceutical compositions
BR112016010669A2 (en) disinfectant composition
DK3043778T3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING REFAMETINIB
IL284419A (en) High potency pancreatin pharmaceutical compositions
AU2014207408A8 (en) Pharmaceutical compositions comprising nitroxyl donors
EP2990038A4 (en) Solid pharmaceutical composition
EP2990039A4 (en) Solid pharmaceutical composition
DK2865275T3 (en) Feed additive containing L-amino acid
MX369290B (en) Fbxo3 inhibitors.
DK3331498T3 (en) NATIONAL COMPOSITION
FR3001392B1 (en) IMPROVED DERMATOLOGICAL COMPOSITION
SG11201601477VA (en) Pharmaceutical composition
EP2994197A4 (en) Pharmaceutical composition and uses thereof
DK2865274T3 (en) Feed additive containing L-amino acid
CL2016001370A1 (en) Biomass formulations
HK1216715A1 (en) Novel hemoglobin-derived peptide based pharmaceutical compositions
PH12015501390A1 (en) Tablets with improved acceptance and good storage stability
FR3027522B1 (en) POROUS COMPOSITION CHARGED AS ACTIVE
MX2015016603A (en) Corticosteroid compositions.
EP2971288A4 (en) Compositions, methods, and computer systems related to making and administering modified t cells
SG10201401381SA (en) Acid injection
HUP1300496A2 (en) Stable pharmaceutical composition